Recent Quarter Total Invested
$1.87 B
Recent Quarter Institutional Ownership Percentage
91.1%
Total Invested of Last Quarter
$1.59 B
Ownership Percentage of Last Quarter
96.09%
Janux Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 9.17 M | $383.95 M | 0.00% | 18.69% |
FMR LLC | 08/13/2024 | 7.78 M | $325.80 M | 0.37% | 15.86% |
ORBIMED ADVISORS LLC | 08/14/2024 | 2.98 M | $124.82 M | -30.31% | 6.08% |
BLACKROCK INC. | 08/13/2024 | 2.34 M | $98.19 M | 38.37% | 4.78% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 2.33 M | $97.52 M | -16.13% | 4.75% |
JANUS HENDERSON GROUP PLC | 08/14/2024 | 1.80 M | $75.39 M | -8.33% | 3.67% |
PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 1.56 M | $65.53 M | 100.00% | 3.19% |
VANGUARD GROUP INC | 08/13/2024 | 1.56 M | $65.42 M | 15.01% | 3.18% |
CITADEL ADVISORS LLC | 08/14/2024 | 1.56 M | $65.23 M | -33.75% | 3.17% |
ECOR1 CAPITAL, LLC | 08/14/2024 | 1.47 M | $61.57 M | 100.00% | 3.00% |
STATE STREET CORP | 08/14/2024 | 1.40 M | $58.70 M | 250.78% | 2.86% |
CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 1.05 M | $43.98 M | 40.00% | 2.14% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 840,219 | $35.20 M | 118.67% | 1.71% |
LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 750,000 | $31.42 M | 400.00% | 1.53% |
VESTAL POINT CAPITAL, LP | 08/14/2024 | 725,000 | $30.37 M | 100.00% | 1.48% |
LORD, ABBETT & CO. LLC | 08/14/2024 | 702,607 | $29.43 M | 29.54% | 1.43% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 624,104 | $26.15 M | 33.48% | 1.27% |
BVF INC/IL | 08/14/2024 | 441,528 | $18.50 M | -84.88% | 0.90% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 396,906 | $16.63 M | 404.81% | 0.81% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 344,672 | $14.44 M | -0.72% | 0.70% |
SAMLYN CAPITAL, LLC | 08/14/2024 | 324,703 | $13.60 M | 9.55% | 0.66% |
WOODLINE PARTNERS LP | 08/14/2024 | 300,825 | $12.60 M | 907.86% | 0.61% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 252,358 | $10.57 M | 1,187.80% | 0.51% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 242,531 | $10.16 M | 58.81% | 0.49% |
ARTAL GROUP S.A. | 08/14/2024 | 203,000 | $8.50 M | 306.00% | 0.41% |
ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 199,384 | $8.35 M | 3.28% | 0.41% |
NORTHERN TRUST CORP | 08/14/2024 | 194,373 | $8.14 M | -3.77% | 0.40% |
POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 136,430 | $5.72 M | 100.00% | 0.28% |
ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 133,000 | $5.57 M | 100.00% | 0.27% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 119,395 | $5.00 M | 407.18% | 0.24% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 115,027 | $4.82 M | 136.26% | 0.23% |
CANDRIAM S.C.A. | 08/05/2024 | 112,004 | $4.69 M | 40.00% | 0.23% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 08/13/2024 | 106,847 | $4.48 M | 2.25% | 0.22% |
RATAN CAPITAL MANAGEMENT LP | 08/14/2024 | 105,757 | $4.43 M | 428.79% | 0.22% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 103,601 | $4.34 M | -53.90% | 0.21% |
D. E. SHAW & CO., INC. | 08/14/2024 | 97,823 | $4.10 M | 79.04% | 0.20% |
STEMPOINT CAPITAL LP | 08/13/2024 | 92,949 | $3.89 M | -23.59% | 0.19% |
MORGAN STANLEY | 08/14/2024 | 81,798 | $3.43 M | -32.53% | 0.17% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 77,516 | $3.25 M | 57.37% | 0.16% |
RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 77,246 | $3.24 M | 100.00% | 0.16% |
MACQUARIE GROUP LTD | 08/09/2024 | 76,601 | $3.21 M | 27.67% | 0.16% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 68,400 | $2.87 M | -23.66% | 0.14% |
TUDOR INVESTMENT CORP ET AL | 08/14/2024 | 67,487 | $2.83 M | 952.02% | 0.14% |
VOYA INVESTMENT MANAGEMENT LLC | 08/14/2024 | 60,578 | $2.54 M | 49.01% | 0.12% |
EAM INVESTORS, LLC | 08/12/2024 | 55,618 | $2.33 M | -0.63% | 0.11% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 55,500 | $2.32 M | -64.83% | 0.11% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 55,212 | $2.31 M | 100.00% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 55,000 | $2.30 M | -29.85% | 0.11% |
UBS GROUP AG | 08/14/2024 | 50,868 | $2.13 M | 129.09% | 0.10% |
GHOST TREE CAPITAL, LLC | 08/14/2024 | 50,000 | $2.09 M | 100.00% | 0.10% |
Janux Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of JANX shares?
During the previous two years, 173 institutional investors and hedge funds held shares of Janux Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 9.17 M
FMR LLC: 7.78 M
ORBIMED ADVISORS LLC: 2.98 M
BlackRock Inc.: 2.34 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.33 M
JANUS HENDERSON GROUP PLC: 1.8 M
-
What percentage of Janux Therapeutics, Inc. stock is owned by institutional investors?
91.10% of Janux Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at JANX ?
Institutional investors have bought a total of 44.90 M shares in the last 24 months. This purchase volume represents approximately $2.04 B in transactions.